Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

533
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
533
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

381
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
381
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

340
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
340
Disassembly of Intermediate Filaments01:35

Disassembly of Intermediate Filaments

2.6K
Intermediate filaments (IFs) do not undergo spontaneous disassembly. Enzymes, kinases, and phosphatases add and remove phosphates from specific sites to regulate their disassembly. The IF concentration in the cytoplasm also regulates the disassembly. If the concentration crosses a threshold, it activates the protein kinases in the vicinity, allowing the phosphorylation of IFs.
Keratin proteins, found at the cell periphery near cell junctions, undergo a cycle of assembly and disassembly. In Type...
2.6K
Types of Intermediate Filaments01:31

Types of Intermediate Filaments

4.8K
The intermediate filaments are an essential component of the cytoskeleton. Presently six types of intermediate filament have been identified. Type I and II are acidic and basic keratin proteins. Type III is of mesodermal origin and comprises four proteins: vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Vimentin is commonly found in mesenchymal cells, desmin in muscle cells, GFAP in astrocytes, while peripherin is found in peripheral nervous system neurons (PNS). Type...
4.8K
Formation of Intermediate Filaments00:57

Formation of Intermediate Filaments

3.9K
Intermediate filaments are cytoskeletal proteins with higher tensile strength and flexibility than microfilaments and microtubules. Unlike the other two cytoskeletal proteins, intermediate filament formation lacks the enzymatic activity to hydrolyze nucleotides like ATP and GTP to generate energy for polymerization. Therefore, the formation of intermediate filaments is multistep self-assembly. The involvement of any accessory proteins in intermediate filament formation has not yet been...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic value of the NAPLES score in patients undergoing LVAD implantation: comparison with established nutritional indices.

BMC cardiovascular disorders·2026
Same author

Association Between SGLT2 Inhibitor Use and New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Implantation: A Doubly Robust Inverse Probability Weighted Analysis.

Journal of clinical medicine·2026
Same author

Catheter ablation of typical atrial flutter in a patient with left ventricular assist device support: a case report.

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology·2026
Same author

Reply to the Letter to the Editor: "Exploring the Multifaceted Nexus of Hypertrophic Cardiomyopathy and Clinical Outcomes".

Anatolian journal of cardiology·2026
Same author

Association Between Hepatitis C Virus Infection and SYNTAX Score in Patients with ST-Segment Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.

Journal of clinical medicine·2026
Same author

Prognostic Value of HALP and AHEAD Scores for Predicting 1-Month Heart Failure Following Myocardial Infarction.

Journal of clinical medicine·2026
Same journal

Repair of Sinus Venosus Atrial Septal Defect in 2 Patients With Severe Pulmonary Arterial Hypertension.

Pulmonary circulation·2026
Same journal

Changes in Arterial-Alveolar Oxygen Gradient and Mixed Venous Oxygen Saturations in Mechanical Thrombectomy for Pulmonary Embolism: A Prospective Cohort Study.

Pulmonary circulation·2026
Same journal

Echocardiography-Derived Exercise Pulmonary Hypertension and Longitudinal Changes in Pulmonary Artery Pressures in Systemic Sclerosis: A Non-Invasive Assessment for Risk Stratification.

Pulmonary circulation·2026
Same journal

Sotatercept as a Therapeutic Option for Systemic Sclerosis-Associated Pulmonary Arterial Hypertension With Features of PVOD/PCH.

Pulmonary circulation·2026
Same journal

Patient Perspectives on Palliative Care in Pulmonary Arterial Hypertension in the United States.

Pulmonary circulation·2026
Same journal

Right Ventricular Mechanical Dyssynchrony Reflects Hemodynamic Load in Pre-Capillary Pulmonary Hypertension.

Pulmonary circulation·2026
See all related articles

Related Experiment Video

Updated: Jan 21, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

773

From Clusters to Outcomes: Machine Learning-Based Phenotyping in Intermediate-High-Risk Acute Pulmonary Embolism.

Barkin Kultursay1, Cihangir Kaymaz2, Hacer Ceren Tokgoz2

  • 1Department of Cardiology Tunceli State Hospital Tunceli Turkey.

Pulmonary Circulation
|January 20, 2026
PubMed
Summary
This summary is machine-generated.

Machine learning identified two intermediate-high-risk pulmonary embolism (PE) phenotypes: one with RV-failure and another with comorbidities. The comorbidity phenotype showed lower early mortality, guiding personalized reperfusion therapy decisions.

More Related Videos

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
07:41

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

3.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.3K

Related Experiment Videos

Last Updated: Jan 21, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

773
Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
07:41

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

3.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.3K

Area of Science:

  • Cardiology
  • Data Science
  • Pulmonary Medicine

Background:

  • Intermediate-high-risk pulmonary embolism (PE) is heterogeneous, and current guidelines may not fully capture risks.
  • Data-driven phenotyping can enhance risk stratification for PE patients.
  • Individualized treatment decisions, including reperfusion therapy, are crucial for managing PE.

Purpose of the Study:

  • To apply unsupervised machine learning to identify distinct phenotypes within intermediate-high-risk PE.
  • To compare clinical characteristics, treatment patterns, and outcomes across identified PE phenotypes.
  • To assess the utility of phenotype-based stratification for guiding reperfusion therapy decisions.

Main Methods:

  • Retrospective analysis of 553 guideline-defined intermediate-high-risk PE patients (2012-2025).
  • Unsupervised machine learning (k-prototypes algorithm) applied to 36 variables for patient clustering.
  • Comparison of clinical, imaging, treatment, and mortality outcomes between identified phenotypes.

Main Results:

  • Two phenotypes were identified: RV-failure (n=360) and comorbidity-dominant (n=193).
  • The comorbidity-dominant phenotype had lower in-hospital mortality (3.6% vs. 7.2%) and was independently associated with reduced early mortality.
  • Both phenotypes showed RV function improvement post-reperfusion, with greater gains in the RV-failure phenotype.

Conclusions:

  • Unsupervised machine learning successfully identified two clinically relevant intermediate-high-risk PE phenotypes.
  • These phenotypes exhibit different early mortality risks but similar long-term outcomes.
  • Phenotype-based assessment can refine risk stratification and inform individualized reperfusion strategies for acute PE.